Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
HK Stock MarketDetailed Quotes
GRAND PHARMA (00512)
- 5.590
- -0.100-1.76%
Trading May 20 13:25 CST
19.84BMarket Cap15.97P/E (TTM)
5.740High5.540Low2.84MVolume5.740Open5.690Prev Close15.85MTurnover0.08%Turnover Ratio15.97P/E (Static)3.55BShares10.20052wk High1.17P/B19.84BFloat Cap5.54052wk Low--Dividend TTM3.55BShs Float10.200Historical High0.260Dividend LFY3.52%Range %0.102Historical Low5.586Avg Price500Lot Size--Div Yield TTM4.65%Div Yield LFY
GRAND PHARMA (00512) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -47.62%1.49B | ---- | 21.68%2.85B | ---- | -6.86%2.34B | ---- | -9.65%2.52B | ---- | 34.35%2.79B | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -16.77%-7.37M | ---- | 18.53%-6.31M | ---- | 60.90%-7.75M | ---- | -105.61%-19.81M | ---- | 46.62%-9.63M | ---- |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 81.87%-1.17M | ---- |
| Attributable subsidiary (profit) loss | 48.86%-76.06M | ---- | -694.69%-148.72M | ---- | -42.89%25.01M | ---- | 138.46%43.79M | ---- | -83.71%-113.86M | ---- |
| Impairment and provisions: | -58.62%71.68M | ---- | 0.59%173.24M | ---- | 821.46%172.22M | ---- | 1,239.78%18.69M | ---- | -94.63%1.4M | ---- |
| -Impairmen of inventory (reversal) | -35.10%32.97M | ---- | 243.93%50.79M | ---- | 180.49%14.77M | ---- | 405.28%5.27M | ---- | -87.24%1.04M | ---- |
| -Impairment of trade receivables (reversal) | -45.72%39.62M | ---- | 26.49%72.98M | ---- | 354.83%57.7M | ---- | -292.31%-22.64M | ---- | 66.06%11.77M | ---- |
| -Impairment of goodwill | ---- | ---- | 25.39%49.07M | ---- | 7.39%39.14M | ---- | --36.44M | ---- | ---- | ---- |
| -Other impairments and provisions | -327.59%-899K | ---- | -99.35%395K | ---- | 16,264.80%60.62M | ---- | 96.72%-375K | ---- | -206.59%-11.42M | ---- |
| Revaluation surplus: | 119.59%133.25M | ---- | -453.08%-680.31M | ---- | -2,093.92%-123.01M | ---- | 101.22%6.17M | ---- | -62.55%-504.91M | ---- |
| -Fair value of investment properties (increase) | 211.15%4.87M | ---- | 19.60%-4.39M | ---- | 74.46%-5.45M | ---- | 27.81%-21.35M | ---- | 35.21%-29.58M | ---- |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | 178.98%31.37M | ---- | -575.69%-39.72M | ---- | --8.35M | ---- |
| -Other fair value changes | 118.99%128.38M | ---- | -353.88%-675.93M | ---- | -321.48%-148.92M | ---- | 113.90%67.24M | ---- | -82.54%-483.68M | ---- |
| Asset sale loss (gain): | 18.05%1.18M | ---- | -92.37%997K | ---- | -56.25%13.06M | ---- | 661.71%29.86M | ---- | 9.28%3.92M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 18.05%1.18M | ---- | -92.37%997K | ---- | 427.63%13.06M | ---- | -36.84%2.48M | ---- | 9.28%3.92M | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | --27.38M | ---- | ---- | ---- |
| Depreciation and amortization: | 15.51%581.9M | ---- | 28.44%503.75M | ---- | -0.68%392.21M | ---- | 16.32%394.91M | ---- | 18.27%339.52M | ---- |
| -Depreciation | -0.11%358.92M | ---- | 11.15%359.32M | ---- | -1.66%323.27M | ---- | 7.60%328.71M | ---- | 17.58%305.5M | ---- |
| -Amortization of intangible assets | 95.53%183.92M | ---- | 223.38%94.06M | ---- | -10.06%29.09M | ---- | 89.97%32.34M | ---- | 46.00%17.02M | ---- |
| Financial expense | -9.93%162.34M | ---- | -12.14%180.24M | ---- | 49.20%205.15M | ---- | 47.90%137.49M | ---- | -19.46%92.96M | ---- |
| Special items | 81.78%-13.93M | ---- | -3,839.95%-76.44M | ---- | 95.50%-1.94M | ---- | -246.94%-43.15M | ---- | 92.47%-12.44M | ---- |
| Operating profit before the change of operating capital | -16.14%2.35B | ---- | -7.30%2.8B | ---- | -2.13%3.02B | ---- | 19.49%3.08B | ---- | 32.84%2.58B | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -169.60%-51.88M | ---- | 174.98%74.54M | ---- | 66.33%-99.41M | ---- | -148.69%-295.28M | ---- | -17.60%-118.74M | ---- |
| Accounts receivable (increase)decrease | -114.54%-973.19M | ---- | -128.82%-453.62M | ---- | 63.07%-198.24M | ---- | 19.59%-536.77M | ---- | -488.35%-667.54M | ---- |
| Accounts payable increase (decrease) | 430.98%586.64M | ---- | -162.16%-177.24M | ---- | 232.11%285.13M | ---- | -139.12%-215.83M | ---- | 2,220.43%551.73M | ---- |
| Special items for working capital changes | -30.16%94.88M | ---- | 222.76%135.85M | ---- | -171.41%-110.66M | ---- | 341.80%154.96M | ---- | -73.37%-64.09M | ---- |
| Cash from business operations | -15.76%2B | ---- | -17.87%2.38B | ---- | 32.12%2.9B | ---- | -3.99%2.19B | ---- | 33.05%2.28B | ---- |
| Other taxs | 26.29%-353.98M | ---- | -1.94%-480.24M | ---- | -34.88%-471.08M | ---- | -25.94%-349.26M | ---- | -6.70%-277.32M | ---- |
| Special items of business | ---- | -66.49%76.05M | ---- | -69.70%226.99M | ---- | -4.93%749.14M | ---- | -19.45%787.96M | ---- | 122.93%978.23M |
| Net cash from operations | -13.10%1.65B | -66.49%76.05M | -21.72%1.9B | -69.70%226.99M | 31.60%2.42B | -4.93%749.14M | -8.13%1.84B | -19.45%787.96M | 37.76%2.01B | 122.93%978.23M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 16.77%7.37M | ---- | -18.53%6.31M | ---- | -60.90%7.75M | ---- | 105.61%19.81M | ---- | -46.62%9.63M | ---- |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | -3.35%192.1M | ---- | -51.64%198.75M | ---- |
| Loan receivable (increase) decrease | 935.91%154.9M | ---- | 131.04%14.95M | ---- | -409.33%-48.18M | ---- | -88.08%15.58M | ---- | 133.05%130.64M | ---- |
| Decrease in deposits (increase) | -167.71%-22.09M | ---- | 1,911.49%32.63M | ---- | -130.71%-1.8M | ---- | -75.46%5.86M | ---- | -74.17%23.9M | ---- |
| Sale of fixed assets | 183.83%2.76M | ---- | -85.31%971K | ---- | 232.61%6.61M | ---- | -91.65%1.99M | ---- | 1,453.82%23.79M | ---- |
| Purchase of fixed assets | -30.65%-726.15M | -2.96%-198.11M | -13.95%-555.78M | 15.53%-192.41M | 22.12%-487.73M | -163.65%-227.78M | -32.79%-626.22M | 68.66%-86.39M | -125.62%-471.57M | -237.10%-275.66M |
| Purchase of intangible assets | -1,104.16%-795.95M | -24,501.46%-50.68M | -563.52%-66.1M | 72.86%-206K | 97.83%-9.96M | 99.52%-759K | -608.15%-458.86M | -304.48%-156.95M | 6.89%-64.8M | ---38.8M |
| Acquisition of subsidiaries | 72.69%-321.83M | 55.35%-321.59M | -568.06%-1.18B | -390.46%-720.29M | 34.47%-176.42M | ---146.86M | -9.70%-269.22M | ---- | ---245.41M | ---125.58M |
| Recovery of cash from investments | 3,161.39%690.54M | --690.54M | -98.71%21.17M | ---- | 20.94%1.64B | ---- | 1,014.89%1.35B | ---- | 981.09%121.48M | ---- |
| Cash on investment | 115.74%42.96M | -369.47%-45.08M | 81.10%-272.88M | 108.08%16.73M | 44.37%-1.44B | 73.03%-207M | -73.43%-2.6B | -219.27%-767.47M | -8.45%-1.5B | 70.37%-240.39M |
| Other items in the investment business | ---- | -32.75%16.66M | ---- | 260.89%24.76M | ---- | -75.58%6.86M | ---- | -61.52%28.1M | -81.87%1.17M | -26.82%73.01M |
| Net cash from investment operations | 51.56%-967.52M | 110.53%91.73M | -287.27%-2B | -51.41%-871.42M | 78.15%-515.75M | 41.43%-575.54M | -33.42%-2.36B | -61.79%-982.72M | -16.91%-1.77B | 23.44%-607.41M |
| Net cash before financing | 787.20%682.01M | 126.04%167.79M | -105.20%-99.25M | -471.20%-644.43M | 468.97%1.91B | 189.14%173.61M | -318.61%-517.43M | -152.52%-194.76M | 513.68%236.7M | 204.58%370.82M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -3.04%4.34B | -19.63%2.31B | 89.08%4.48B | 169.02%2.87B | -23.96%2.37B | 39.17%1.07B | 57.32%3.12B | -52.96%767.23M | -7.51%1.98B | 15.08%1.63B |
| Refund | -27.15%-4.21B | -34.05%-2.22B | 3.39%-3.31B | -63.88%-1.66B | -55.70%-3.42B | -27.89%-1.01B | -36.12%-2.2B | 32.10%-791.83M | 15.04%-1.62B | -69.20%-1.17B |
| Interest paid - financing | 13.24%-156.37M | 12.96%-74.97M | 11.80%-180.24M | 23.93%-86.14M | -48.63%-204.36M | -79.13%-113.23M | -47.90%-137.49M | -167.05%-63.21M | 19.46%-92.96M | ---23.67M |
| Dividends paid - financing | 2.33%-911.44M | 1.35%-910.47M | -78.54%-933.18M | -85.71%-922.89M | -31.32%-522.67M | -27.27%-496.94M | 0.42%-398.01M | 0.35%-390.45M | -21.30%-399.68M | ---391.83M |
| Absorb investment income | ---- | ---- | --4.69M | ---- | ---- | ---- | ---- | ---- | --17.89M | ---- |
| Other items of the financing business | ---- | 24.81%-14.97M | ---- | 81.14%-19.91M | -84.18%-81.01M | -107.50%-105.56M | 79.82%-43.99M | -989.99%-50.87M | -2,058.19%-218.02M | 128.69%5.72M |
| Net cash from financing operations | -3,276.25%-951.54M | -598.19%-916.64M | 101.59%29.96M | 127.85%183.99M | -677.80%-1.89B | -24.85%-660.64M | 198.15%327M | -1,060.77%-529.14M | -143.03%-333.17M | -92.22%55.07M |
| Effect of rate | 0.52%70.92M | 21.93%-113.03M | 156.88%70.56M | 45.03%-144.77M | -4.76%-124.06M | -4,547.32%-263.37M | -1,036.84%-118.42M | -92.10%5.92M | -79.06%12.64M | 545.48%74.93M |
| Net Cash | -289.01%-269.53M | -62.64%-748.85M | -450.84%-69.29M | 5.46%-460.43M | 110.37%19.75M | 32.72%-487.03M | -97.39%-190.43M | -269.97%-723.9M | -113.45%-96.48M | 20.44%425.89M |
| Begining period cash | 0.09%1.34B | 0.09%1.34B | -7.22%1.34B | -7.22%1.34B | -17.62%1.44B | -17.62%1.44B | -4.56%1.75B | -4.56%1.75B | 73.39%1.84B | 73.39%1.84B |
| Cash at the end | -14.81%1.14B | -34.77%479.1M | 0.09%1.34B | 5.90%734.5M | -7.22%1.34B | -32.98%693.61M | -17.62%1.44B | -55.73%1.03B | -4.56%1.75B | 67.44%2.34B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"